Effects of oral and inhaled corticosteroid on lymphocyte β2-adrenoceptor function in asthmatic patients

British Journal of Clinical Pharmacology

Volumn 44, Issue 6, 1997, Pages 565-568

  Tan, Kia Soong ^a   McFarlane, Lesley C ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Asthma; Fluticasone; Lymphocyte 2 adrenoceptors; Prednisolone

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; FLUTICASONE PROPIONATE; PLACEBO; PREDNISOLONE;

ADRENAL SUPPRESSION; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; LYMPHOCYTE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR UPREGULATION; SIDE EFFECT;

EID: 0030707790     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00627.x     Document Type: Article

References (19)

1. The British Guidelines on asthma management. 1995 review and position statement. Thorax 1997; 52(Suppl 1): S1-S21.
2. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989; 321: 1517-1527.
3. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised, double-blind, parallel-group controlled study. J Allergy Clin Immunol 1992; 90: 32-42.
4. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-674.
5. Jeffrey PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson S-Å. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
6. Burke C, Power CK, Norris A, Condez A, Schemekel B, Poulter LW. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 1992; 4: 73-79.
7. Hui KKP, Connolly ME, Tashkin DP. Reversal of human lymphocyte β-adrenoceptor desensitisation by glucocorticoids. Clin Pharmacol Ther 1982; 32: 566-571.
8. 2-adrenoceptors: accelerated restoration of beta-adrenergic responses by prednisolone and ketotifen. J Clin Invest 1985; 76: 1096-1101.
9. Brodde OE, Howe U, Egerzegi S, Konietzko N, Michel MC. Effects of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators. Eur J Clin Pharmacol 1988; 34: 145-150.
10. Newnham DM, McDevitt DG, Lipworth BJ. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 1994; 97: 29-37.
11. 2-adrenoceptor responses after regular twice-daily treatment with eformoterol dry powder in asthmatic patients. Thorax 1995; 50: 497-504.
12. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice-daily salmeterol in asthmatic patients. Lancet 1995; 346: 201-206.
13. 2-adrenoceptor function in asthmatic patients. Chest 1996; 109: 343-347.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987; 36: 225-244.
15. Hayes MJ, Quing F, Rhodes CG, et al. In viva quantification of human pulmonary β-adrenoceptors: effect of β-agonist therapy. Am J Respir Crit Care Med 1996; 154: 1277-1283.
16. Thorsson L, Dahlström K, Edsbäcker S, Källèn A, Paulson J, Wirèn J-E. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155-161.
17. 2-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab 1980; 51: 599-605.
18. 2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 12: L41-L46.
19. 2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 12: L41-L46.